The outcome of fluocinolone acetonide intravitreal implant is predicted by the response to dexamethasone implant in diabetic macular oedema-Reference-Cited by-同舟云学术

The outcome of fluocinolone acetonide intravitreal implant is predicted by the response to dexamethasone implant in diabetic macular oedema

Published:2021-01-21 Issue:12 Volume:35 Page:3232-3242
ISSN:0950-222X
Container-title:Eye
language:en
Short-container-title:Eye

Author:

Cicinelli Maria Vittoria^ORCID,Rosenblatt Amir,Grosso Domenico,Zollet Piero,Capone Luigi,Rabiolo Alessandro,Lattanzio Rosangela,Loewenstein Anat,Bandello Francesco,Nassisi Marco,Tan Anna,Reynolds Rhianon,Singh Sumit Randhir,Vaezi Kaivon P.,Giocanti-Aurégan Audrey,Weinberg Tamir,Faes Livia,Schwartz Roy,Reyes Denis Yurani Anaya,Savastano Alfonso,Touhami Sara,Garcia Humberto Ruiz,Pohlmann Dominika,Plant Adam,Ventura Camila V.,Chatziralli Irini,Phasukkijwatana Nopasak,Ruiz-Medrano Jorge,Yuan Miner,Yılmaz İhsan,Vogt Denise,Ting Daniel Shu Wei,Mustapha Mushawiahti,Mendaro Marcos,

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

https://www.nature.com/articles/s41433-020-01373-1.pdf

Reference39 articles.

1. Bandello F, Cicinelli MV, Parodi MB. Anti-VEGF molecules for the management of diabetic macular edema. Curr Pharm Des. 2015;21:4731–7.

2. Cicinelli MV, Cavalleri M, Querques L, Rabiolo A, Bandello F, Querques G. Early response to ranibizumab predictive of functional outcome after dexamethasone for unresponsive diabetic macular oedema. Br J Ophthalmol. 2017;101:1689–93.

3. Schmidt-Erfurth U, Garcia-Arumi J, Bandello F, Berg K, Chakravarthy U, Gerendas BS, et al. Guidelines for the management of diabetic macular edema by the European Society of Retina Specialists (EURETINA). Ophthalmologica. 2017;237:185–222.

4. Whitcup SM, Cidlowski JA, Csaky KG, Ambati J. Pharmacology of corticosteroids for diabetic macular edema. Invest Ophthalmol Vis Sci. 2018;59:1–12.

5. Boyer DS, Yoon YH, Belfort R Jr, Bandello F, Maturi RK, Augustin AJ, et al. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology. 2014;121:1904–14.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of 0.19-mg Fluocinolone Acetonide Implant in Postoperative Cystoid Macular Edema after Pars Plana Vitrectomy;Ophthalmology Retina;2024-07

2. The Treatment of Diabetic Retinal Edema with Intravitreal Steroids: How and When;Journal of Clinical Medicine;2024-02-26

3. Efficacity and Safety of the Fluocinolone Acetonide Implant in Uveitic Macular Edema: A Real-Life Study from the French Uveitis Network;Journal of Personalized Medicine;2024-02-24

4. Real-world experience with fluocinolone acetonide intravitreal implant in patients with diabetic macular edema;European Journal of Ophthalmology;2024-02-23

5. Safety and Efficacy of Dexamethasone Intravitreal Implant Given Either First-Line or Second-Line in Diabetic Macular Edema;Patient Preference and Adherence;2023-12